...
首页> 外文期刊>Human Pathology >Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation
【24h】

Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation

机译:靶向Net1的短干扰RNA通过VEGF下调降低了体内宫颈鳞状细胞癌的血管生成和肿瘤生长

获取原文
获取原文并翻译 | 示例

摘要

Summary Net1, a guanine nucleotide exchange factor, is implicated in cancer cell invasion through activation of RhoA. However, there is still no report on the association between Net1 and cancer angiogenesis. The current study was designed to explore the role of Net1 in the angiogenesis of cervical squamous cell carcinoma (CSCC) and further observe the effects of Net1 short interfering RNA (siRNA) on the tumor growth. Net1 was overexpressed in CSCC samples (n = 80), correlated with the cancer microvessel density ( r = 0.223, P = .026), and related to aggressive clinical behaviors, including depth of cervical wall invasion ( P = .041), parametrial involvement ( P = .037), lymph node metastasis ( P = .021), and vascular invasion ( P = .018). Human umbilical vein endothelial cells treated with supernatant of SiHa cells with Net1 siRNA showed significantly decreased proliferation (0.75 ± 0.038 versus 1.0 ± 0.015, P .001), migration (39.3 ± 6.5 versus 66.0 ± 10.1, P = .019), and tube formation (13.5 ± 3.05 versus 21.7 ± 2.89, P = .030) compared with those human umbilical vein endothelial cells treated with normal SiHa cells supernatant. Net1 siRNA of SiHa decreased VEGF expression level (0.60 ± 0.026 versus 0.78 ± 0.031, P = .02). Furthermore, Net1 siRNA significantly reduced tumor growth ( P = .037) and microvessel density (5.8 ± 0.43 versus 3.4 ± 0.55, P = .012) and decreased the expression level of VEGF (0.31 ± 0.002 versus 0.39 ± 0.004, P .001) in CSCC. In conclusion, Net1 promotes the angiogenesis of CSCC, and siRNA targeting Net1 can effectively reduce the angiogenesis and thus inhibit the tumor growth of CSCC in vivo. Highlights ? Net1 is overexpressed in squamous cell carcinoma and associated with the cancer angiogenesis. ? Net1 siRNA impairs the angiogenesis-inducing ability of cervical squamous carcinoma cells. ? Net1 siRNA down-regulates the VEGF expression level of cervical squamous carcinoma cells. ? Net1 knockdown reduces the angiogenesis and tumor growth of cervical squamous carcinoma in vivo. ]]>
机译:概述Net1,鸟嘌呤核苷酸交换因子,通过激活RhOA涉及癌细胞侵袭。但是,仍然没有关于Net1和癌症血管生成之间的关联报告。目前的研究旨在探讨Net1在宫颈鳞状细胞癌(CSCC)的血管生成中的作用,并进一步观察Net1短干扰RNA(siRNA)对肿瘤生长的影响。 Net1在CSCC样品(n = 80)中过表达,与癌症微血管密度(r = 0.223,p = .026)相关,与侵袭性临床行为相关,包括颈壁侵袭的深度(p = .041),参数参与(p = .037),淋巴结转移(p = .021)和血管侵袭(p = .018)。用Net1 siRNA的Siha细胞上清液处理的人脐静脉内皮细胞显着降低(0.75±0.038与1.0±0.015,P& .001),迁移(39.3±6.5与66.0±10.1,p = .019),与用正常Siha细胞上清液处理的人脐静脉内皮细胞相比,管形成(13.5±3.05与21.7±2.89)。 SiHa的Net1 siRNA降低VEGF表达水平(0.60±0.026对0.78±0.031,p = .02)。此外,Net1 siRNA显着降低了肿瘤生长(P = .037)和微血管密度(5.8±0.43与3.4±0.55,p = .012)并降低VEGF的表达水平(0.31±0.002与0.39±0.004,P< .001)在CSCC中。总之,Net1促进CSCC的血管生成,靶向Net1的siRNA可以有效地降低血管生成,从而抑制CSCC在体内CSCC的肿瘤生长。强调 ? Net1在鳞状细胞癌中过表达并与癌症血管生成相关。还Net1 siRNA损害宫颈鳞状癌细胞的血管生成诱导能力。还Net1 siRNA下调宫颈鳞状癌细胞的VEGF表达水平。还Net1敲低降低了体内宫颈鳞状癌的血管生成和肿瘤生长。 ]]>

著录项

  • 来源
    《Human Pathology》 |2017年第2017期|共10页
  • 作者单位

    Department of Pathology Basic Medical College of Nanchang University;

    Department of Pathology Basic Medical College of Nanchang University;

    Department of Pathology the First Affiliated Hospital of Sun Yat-sen University;

    Department of Pathology Basic Medical College of Nanchang University;

    Department of Pathology Basic Medical College of Nanchang University;

    Department of Pathology Basic Medical College of Nanchang University;

    Department of Pathology Basic Medical College of Nanchang University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

    Net1; Angiogenesis; Cervical sqaumous cell carcinoma; VEGF; MVD;

    机译:net1;血管生成;宫颈鳞状细胞癌;VEGF;MVD;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号